Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.
We treated 29 rheumatoid arthritis patients with levamisole. on the basis of a 25% improvement in any 3 of 6 measurements 95% of the patients had a favourable response within 20 weeks. However, 64% of the patients discontinued levamisole by 40 to 60 weeks because of rash or secondary treatment failu...
שמור ב:
| הוצא לאור ב: | Ann Rheum Dis |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
1979
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1000335/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/375847/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.38.2.122 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
